Search results
Pawsitive Life Rescue hosts low-cost pet vaccine
KRQE & KASA FOX 2 Albuquerque· 5 days agoALBUQUERQUE, N.M. (KRQE) – A local nonprofit is serving four-legged friends in the community by making sure they remain healthy. “Pawsitive Life Rescue” held a low-cost vaccine cli…
Pirates preview: Weekend series against Rays starts Friday night
WPXI· 10 hours agoThe Pirates (36-38) will be back in action at PNC Park on Friday night for the start of a three-game...
A Lesbian Actress Playing an Anti-Gay, Anti-Trans Superhero on ‘The Boys’? Count Her In!
The Hollywood Reporter· 14 hours agoFirecracker, the latest mutant to join Amazon’s superhero satire The Boys in its new fourth season,...
Dissolving Big Pharma's Illusion of 'Safety'
Mercola· 6 days agoIn that book, Humphries details how vaccine science has been misrepresented to portray them as safe and effective, when in reality they’re neither. Humphries first became ...
Big News for Older Adults: Pneumococcal Vaccine Approved
WebMD· 4 days agoThere’s a new tool to fight invasive pneumococcal disease and pneumococcal pneumonia in adults, as the FDA approved Merck’s new vaccine designed to prevent the disorders.
7 important health stories this week you simply can't miss
Fox News via Yahoo News· 6 days agoAs you prepare for the week ahead, check out some of the top recent stories in Health that you may...
A Pentagon-approved bot attack attempted to thwart global COVID-19 vaccinations, report finds
Mashable· 6 days agoAccording to a new investigative report by Reuters, the Pentagon ran a year-long vaccine...
'Exciting' new Parkinson's treatment may cure root cause
Newsweek· 2 days agoAn "exciting" new Parkinson's disease drug promises to not only treat but to cure the condition at...
Trump zeroes in on his VP finalists: From the Politics Desk
NBC NEWS· 8 hours agoWelcome to the online version of From the Politics Desk, an evening newsletter that brings you the...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 1 day agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
